- Home
- AXIL vs MREO Comparison
AXIL vs MREO Comparison
Compare AXIL & MREO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AXIL | MREO |
|---|---|---|
| Founded | 2015 | 2015 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.7M | 52.5M |
| IPO Year | 2017 | 2017 |
Fundamental Metrics
Financial Performance| Metric | AXIL | MREO |
|---|---|---|
| Price | $6.85 | $0.31 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $1.50 |
| AVG Volume (30 Days) | 24.8K | ★ 4.2M |
| Earning Date | 04-08-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 16.67 |
| EPS | ★ 0.15 | N/A |
| Revenue | ★ $26,257,522.00 | $500,000.00 |
| Revenue This Year | N/A | $5,184.20 |
| Revenue Next Year | N/A | $55.51 |
| P/E Ratio | $46.67 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.28 | $0.20 |
| 52 Week High | $10.25 | $2.94 |
Technical Indicators
Market Signals| Indicator | AXIL | MREO |
|---|---|---|
| Relative Strength Index (RSI) | 48.01 | 51.94 |
| Support Level | $6.63 | $0.22 |
| Resistance Level | $7.33 | $0.36 |
| Average True Range (ATR) | 0.33 | 0.05 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 54.69 | 59.37 |
Price Performance
Historical ComparisonAbout AXIL AXIL Brands Inc.
AXIL Brands Inc is a company which is is a manufacturer and marketer of premium hearing enhancement and protection products, including ear plugs, earmuffs, and ear buds, and outdoor speakers, under the AXIL brand. AXIL delivers top hearing enhancement, protection, & audio devices. From ultra comfortable fitting processes, to stereo quality sound performance, to reliable & durable engineering. The company operates two operating segments: hearing enhancement and protection, and hair and skin care.
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).